Reducing intravenous (IV) isatuximab delivery from 75 minutes to 30 minutes could provide a wealth of benefits to patients ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Currently, individuals with high cholesterol are typically subjected to complex treatment plans, often involving a variety of ...

MRI-Compatible IV Infusion Pump Systems MarketThe global market for MRI-compatible IV infusion pump systems is set for significant expansion, driven by advancements in medical imaging and increasing ...

The owners and staff of Woodstock Infusions (L-R): manager Tania Cawthron, owner and registered nurse Kim Rice, founder and owner Marc Baumslag and registered nurse Anna Schlosser. (Photos by Lauren ...

GREENFIELD — Sue Ann Wortman Cancer Center is doubling the size of its infusion center, where patients receive chemotherapy ...

Financing led by Nantahala Capital and ADAR1 Partners, LP with participation from new and existing healthcare-focused institutional investors$15 ...

The FDA has approved a third biosimilar for tocilizumab, called Avtozma, the second such biosimilar to be available in both intravenous and subcutaneous formulations, according to a press release.

Celebrities and wellness influencers are getting routine NAD+ infusions as an anti-aging hack, but are these expensives IV ...